Medication for Adults with ADPKD now available for use in Canada

Effective June 3, 2015, JINARC™ (tolvaptan) was made commercially available for use in Canada. It is the first treatment in Canada for patients living with autosomal dominant polycystic kidney disease (ADPKD)

Celebrating Excellence

The Kidney Foundation of Canada is pleased to have the opportunity each year to celebrate its many volunteers and supporters through its National Recognition Program. Most recently, Foundation representatives had the opportunity to present Alex Lifeson, guitarist with the Canadian band RUSH, with a Public Awareness Award. 

Priority Setting Survey in Donation and Transplantation

Your experiences as a patient, caregiver, researcher and or healthcare professional can help identify the top research priorities in transplantation and donation within the Canadian National Transplant Research Program (CNTRP) in order to improve the treatment and the quality of life of transplanted patients and patients waiting for a transplant. For more details visit www.kidney.ca/surveys.

Impact Report 2014

Your support makes a positive impact in the kidney community! Download our Impact Report 2014 to see how your giving makes a difference.


Upcoming Events


More Events

Eat Renal-Friendly, with June Martin
Spotlight on phosphorus: the nutrition facts table’s missing mineral

Northern Alberta & Territories Branch - 11227 Jasper Avenue, 2nd Floor, Edmonton AB T5K 0L5 - Tel.: (780) 451-6900 / 1-800-461-9063
Charitable Registration Number: 107567398RR0001